PL3274710T3 - Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorów - Google Patents
Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorówInfo
- Publication number
- PL3274710T3 PL3274710T3 PL16716342T PL16716342T PL3274710T3 PL 3274710 T3 PL3274710 T3 PL 3274710T3 PL 16716342 T PL16716342 T PL 16716342T PL 16716342 T PL16716342 T PL 16716342T PL 3274710 T3 PL3274710 T3 PL 3274710T3
- Authority
- PL
- Poland
- Prior art keywords
- cells
- epithinal
- rpe
- potential
- determination
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title 1
- 108091008695 photoreceptors Proteins 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562136660P | 2015-03-23 | 2015-03-23 | |
| EP16716342.7A EP3274710B1 (en) | 2015-03-23 | 2016-03-23 | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| PCT/US2016/023839 WO2016154357A1 (en) | 2015-03-23 | 2016-03-23 | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3274710T3 true PL3274710T3 (pl) | 2021-12-27 |
Family
ID=55752717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16716342T PL3274710T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorów |
| PL21167900.6T PL3869195T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21167900.6T PL3869195T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11422125B2 (pl) |
| EP (3) | EP4343331A3 (pl) |
| JP (3) | JP6902474B2 (pl) |
| KR (2) | KR102577776B1 (pl) |
| CN (3) | CN113930476B (pl) |
| AU (3) | AU2016235176B2 (pl) |
| CA (2) | CA2980580C (pl) |
| DK (1) | DK3274710T3 (pl) |
| ES (2) | ES2980659T3 (pl) |
| HU (1) | HUE054946T2 (pl) |
| IL (3) | IL303401A (pl) |
| MX (2) | MX395233B (pl) |
| PL (2) | PL3274710T3 (pl) |
| PT (2) | PT3274710T (pl) |
| SG (3) | SG10201907918VA (pl) |
| WO (1) | WO2016154357A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2874953T3 (es) | 2010-07-23 | 2021-11-05 | Astellas Inst For Regenerative Medicine | Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células |
| EP4343331A3 (en) * | 2015-03-23 | 2024-06-19 | Astellas Institute for Regenerative Medicine | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| AU2016308818B2 (en) | 2015-08-18 | 2022-04-21 | Astellas Institute For Regenerative Medicine | Clinical formulations |
| MX2022005134A (es) | 2019-10-30 | 2022-05-30 | Astellas Inst For Regenerative Medicine | Metodos para producir celulas del epitelio pigmentario retiniano. |
| KR102452657B1 (ko) * | 2020-09-09 | 2022-10-11 | 조선대학교 산학협력단 | Noxa 단백질에서 유래한 펩타이드를 포함하는 세포외 소포 생산 촉진용 조성물 및 이를 이용한 세포외 소포의 생산 방법 |
| DE102022103893A1 (de) * | 2022-02-18 | 2023-08-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Membranvesikel, die einen spektroskopisch nachweisbaren Indikator beinhalten, und deren Verwendung in einem Verfahren zum Nachweis der Phagozytose-Funktion bei biologischen Zellen |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| EP1196426A4 (en) | 1999-06-30 | 2003-09-03 | Advanced Cell Tech Inc | CYTOPLASMATIC TRANSFER FOR DE-DIFFERENTIATION OF VASCELL CELLS |
| US20040199935A1 (en) | 1999-06-30 | 2004-10-07 | Chapman Karen B. | Cytoplasmic transfer to de-differentiate recipient cells |
| WO2001018236A1 (en) | 1999-09-07 | 2001-03-15 | Advanced Cell Technology, Inc. | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| US20050255596A1 (en) | 1999-09-07 | 2005-11-17 | West Michael D | Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer |
| US20040180430A1 (en) | 1999-09-07 | 2004-09-16 | West Michael D. | Methods of restoring telomere length and extending cell lifespan using nuclear transfer |
| CA2388510A1 (en) | 1999-11-02 | 2001-05-10 | James M. Robl | Use of haploid genomes for genetic diagnosis, modification and multiplication |
| CA2394812A1 (en) | 1999-12-20 | 2001-06-28 | Anthony C.F. Perry | A method to produce cloned embryos and adults from cultured cells |
| CN1425064A (zh) | 1999-12-20 | 2003-06-18 | 马萨诸塞大学 | 通过交叉物种核移植制备的胚胎或干样细胞 |
| WO2002072762A2 (en) | 2001-03-08 | 2002-09-19 | Advanced Cell Technology, Inc. | Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| WO2002073188A1 (en) | 2001-03-13 | 2002-09-19 | Advanced Cell Technology, Inc. | Method for generating replacement cells and/or tissues |
| IL160507A0 (en) | 2001-08-24 | 2004-07-25 | Advanced Cell Tech Inc | Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
| US20050025750A1 (en) | 2002-12-27 | 2005-02-03 | Fissore Rafael A. | Sperm-induced cellular activation |
| NZ548623A (en) | 2004-01-02 | 2010-04-30 | Advanced Cell Tech Inc | Novel culture systems for ex vivo development of stem cells in telolecithal or eutelolecithal eggs |
| SG188122A1 (en) | 2004-01-23 | 2013-03-28 | Advanced Cell Tech Inc | Improved modalities for the treatment of degenerative diseases of the retina |
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| US20190282622A1 (en) | 2004-01-23 | 2019-09-19 | Astellas Institute For Regenerative Medicine | Modalities for the treatment of degenerative diseases of the retina |
| GB0407836D0 (en) | 2004-04-06 | 2004-05-12 | Univ Cambridge Tech | Fluorescent dyes and complexes |
| CA3015835A1 (en) | 2004-11-04 | 2006-05-18 | Astellas Institute For Regenerative Medicine | Derivation of embryonic stem cells |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| US20060263338A1 (en) | 2005-03-04 | 2006-11-23 | Jacoby Douglas B | Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts |
| JP2008540536A (ja) | 2005-05-09 | 2008-11-20 | マイトジェン， インコーポレイテッド | 心疾患の患者における補助治療としての細胞性心筋形成術 |
| CA2659945C (en) | 2005-08-03 | 2014-12-16 | Advanced Cell Technology, Inc. | Improved methods of reprogramming animal somatic cells |
| WO2007047894A2 (en) | 2005-10-20 | 2007-04-26 | Advanced Cell Technology, Inc. | Totipotent, nearly totipotent or pluripotent mammalian cells homozygous or hemizygous for one or more histocompatibility antigen genes |
| KR101602951B1 (ko) | 2006-05-03 | 2016-03-14 | 오카타 세라퓨틱스, 인크. | 배아 줄기 세포 및 배-유도 세포의 유도 |
| EP3190178A1 (en) | 2007-02-23 | 2017-07-12 | Astellas Institute for Regenerative Medicine | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
| ES2764473T3 (es) | 2007-10-12 | 2020-06-03 | Astellas Inst For Regenerative Medicine | Métodos mejorados para producir células RPE y composiciones de células RPE |
| US20110028780A1 (en) | 2007-12-19 | 2011-02-03 | Robert Lanza | Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom |
| WO2011063005A2 (en) | 2009-11-17 | 2011-05-26 | Advanced Cell Technology, Inc. | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| ES2874953T3 (es) | 2010-07-23 | 2021-11-05 | Astellas Inst For Regenerative Medicine | Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células |
| US20120184035A1 (en) | 2011-01-13 | 2012-07-19 | Sadhana Agarwal | Methods and Compositions For Reprogramming Cells |
| CA2855941A1 (en) * | 2011-11-14 | 2013-05-23 | Advanced Cell Technology, Inc. | Pharmaceutical preparations of human rpe cells and uses thereof |
| KR102108245B1 (ko) | 2011-11-30 | 2020-05-08 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 중간엽 간질 세포 및 이에 관련된 용도 |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| CA2858173C (en) | 2011-12-06 | 2023-09-26 | Advanced Cell Technology, Inc. | Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof |
| US9511152B2 (en) | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
| EP3973967A1 (en) | 2012-12-21 | 2022-03-30 | Astellas Institute for Regenerative Medicine | Methods for production of platelets from pluripotent stem cells and compositions thereof |
| US11241460B2 (en) | 2013-03-15 | 2022-02-08 | Astellas Institute For Regenerative Medicine | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| AU2014233403B2 (en) | 2013-03-15 | 2019-08-01 | Astellas Institute For Regenerative Medicine | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| US20160175362A1 (en) | 2014-03-14 | 2016-06-23 | Ocata Therapeutics, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| US20160175361A1 (en) | 2014-03-14 | 2016-06-23 | Advanced Cell Technology, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| PT3189135T (pt) | 2014-09-05 | 2021-08-19 | Astellas Inst For Regenerative Medicine | Células ganclionares retinianas e seus progenitores |
| EP4343331A3 (en) | 2015-03-23 | 2024-06-19 | Astellas Institute for Regenerative Medicine | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| AU2016308818B2 (en) | 2015-08-18 | 2022-04-21 | Astellas Institute For Regenerative Medicine | Clinical formulations |
-
2016
- 2016-03-23 EP EP24154934.4A patent/EP4343331A3/en active Pending
- 2016-03-23 WO PCT/US2016/023839 patent/WO2016154357A1/en not_active Ceased
- 2016-03-23 CN CN202111336261.7A patent/CN113930476B/zh active Active
- 2016-03-23 CN CN202411118882.1A patent/CN118995872A/zh active Pending
- 2016-03-23 EP EP21167900.6A patent/EP3869195B1/en active Active
- 2016-03-23 ES ES21167900T patent/ES2980659T3/es active Active
- 2016-03-23 CA CA2980580A patent/CA2980580C/en active Active
- 2016-03-23 PL PL16716342T patent/PL3274710T3/pl unknown
- 2016-03-23 JP JP2017550191A patent/JP6902474B2/ja active Active
- 2016-03-23 PL PL21167900.6T patent/PL3869195T3/pl unknown
- 2016-03-23 PT PT167163427T patent/PT3274710T/pt unknown
- 2016-03-23 MX MX2017012259A patent/MX395233B/es unknown
- 2016-03-23 KR KR1020177030540A patent/KR102577776B1/ko active Active
- 2016-03-23 CA CA3188112A patent/CA3188112A1/en active Pending
- 2016-03-23 ES ES16716342T patent/ES2877400T3/es active Active
- 2016-03-23 IL IL303401A patent/IL303401A/en unknown
- 2016-03-23 KR KR1020237030529A patent/KR20230132893A/ko active Pending
- 2016-03-23 DK DK16716342.7T patent/DK3274710T3/da active
- 2016-03-23 HU HUE16716342A patent/HUE054946T2/hu unknown
- 2016-03-23 IL IL293110A patent/IL293110B2/en unknown
- 2016-03-23 CN CN201680029779.7A patent/CN107889507B/zh active Active
- 2016-03-23 AU AU2016235176A patent/AU2016235176B2/en active Active
- 2016-03-23 SG SG10201907918V patent/SG10201907918VA/en unknown
- 2016-03-23 EP EP16716342.7A patent/EP3274710B1/en active Active
- 2016-03-23 PT PT211679006T patent/PT3869195T/pt unknown
- 2016-03-23 SG SG10201912315UA patent/SG10201912315UA/en unknown
- 2016-03-23 US US15/560,584 patent/US11422125B2/en active Active
- 2016-03-23 SG SG11201707775TA patent/SG11201707775TA/en unknown
-
2017
- 2017-09-24 IL IL254617A patent/IL254617B/en unknown
- 2017-09-25 MX MX2022010736A patent/MX2022010736A/es unknown
-
2021
- 2021-06-21 JP JP2021102569A patent/JP7386206B2/ja active Active
-
2022
- 2022-08-15 US US17/887,783 patent/US11680941B2/en active Active
- 2022-08-17 AU AU2022218516A patent/AU2022218516B2/en active Active
-
2023
- 2023-05-12 US US18/316,785 patent/US20230408489A1/en active Pending
- 2023-11-13 JP JP2023192860A patent/JP2024037720A/ja active Pending
-
2025
- 2025-09-05 AU AU2025226799A patent/AU2025226799A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271025A (en) | Multibiotic agents and methods of using the same | |
| CL2016001868A1 (es) | Proteinas de union y sus métodos de uso | |
| IL282048A (en) | Oxysterols and methods of use thereof | |
| HUE058755T2 (hu) | Anti-tigit antigénkötõ proteinek és felhasználásuk módszerei | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| IL254734B1 (en) | Modified t cells and methods of making and using the same | |
| BR112017004802A2 (pt) | anticorpos anti-cll-1 e imunoconjugados | |
| EP3471749A4 (en) | METHOD AND COMPOSITIONS FOR DETECTING A TARGET RNA | |
| IL251970B (en) | Anti-cd79b antibodies and methods of use | |
| KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
| MX384364B (es) | Anticuerpos anti-pd-l1 y sus usos de diagnóstico. | |
| HUE046756T2 (hu) | Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei | |
| HUE047784T2 (hu) | Anti-TIM3 antitestek és alkalmazási eljárások | |
| IL248519A0 (en) | Bioceramic compositions and biomodulatory uses thereof | |
| HUE061084T2 (hu) | PVRIG elleni antitestek és alkalmazási eljárások | |
| CR20170240A (es) | Anticuerpos anti-interleucina-33 y sus usos | |
| IL269334A (en) | Improved t cell compositions and methods | |
| MA42243A (fr) | Anticorps de facteur xi et méthodes d'utilisation | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| BR112018000129A2 (pt) | oxiesteróis e seus métodos de utilização | |
| PL3250610T3 (pl) | Przeciwciała anty-FcRn i sposoby ich stosowania | |
| EP3394065A4 (en) | TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE AND METHOD OF USE THEREOF | |
| EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
| EP3108229C0 (en) | NANOPORES-BASED ANALYSIS OF PROTEIN CHARACTERISTICS | |
| EP3303435A4 (en) | HYDROFLUOROLEFINES AND METHOD OF USE THEREOF |